Health Tech Companies Announce Substantial Funding in February
In February 2026, multiple health tech companies, including Talkiatry and Honest Health, completed major funding rounds totaling hundreds of millions of dollars, aimed at enhancing their services and expanding their reach, according to Dealbreaker.
Deal Details
The funding landscape for health tech saw several notable rounds in February. Talkiatry, a New York City-based provider of online psychiatric and therapy services for conditions such as ADHD, anxiety, bipolar disorder, and depression, raised $210 million in a Series D round. This round was led by Perceptive Advisors and included investors like Andreessen Horowitz, blisce/, Sofina, and Left Lane Capital, bringing Talkiatry’s total funding to more than $400 million. The company plans to use the funds to invest in its technology and expand services across various levels of care.
Honest Health, based in Nashville and focused on value-based care enablement for health systems and providers, secured $140 million in funding. This round was led by NewSpring Healthcare, with participation from K2 HealthVentures, Rubicon Founders, Oak HC/FT, Welsh, Carson, Anderson & Stowe, and Durable Capital Partners. The investment will support Honest Health’s expansion into new markets and the formation of partnerships with health systems, providers, and payers.
Other significant rounds included Solace, a Redwood, California-based company that connects patients with healthcare advocates for navigating the system, raising $130 million in a Series C round led by IVP and including Menlo Ventures, SignalFire, Torch Capital, Inspired Capital, and RiverPark Ventures. Solace intends to expand its network of advocates and invest in its platform and clinical research. Garner Health, a digital platform with a claims database of over 60 billion medical records to help patients find top doctors, raised $118 million in a Series D round led by Kleiner Perkins, with participation from Redpoint, Maverick, Kaiser Permanente Ventures, Mercy, and Plus Capital, bringing its total to about $200 million for expanding its doctor ranking and navigation capabilities. Finally, Midi Health, a Palo Alto-based virtual clinic for women aged 35 to 65 dealing with perimenopause and menopause, completed a $100 million Series D round led by Goodwater Capital and including Foresite Capital, Serena Ventures, Advance Venture Partners, GV, Emerson Collective, SemperVirens, and McKesson Ventures, achieving a valuation over $1 billion to support its services.
Background on the Companies
These funding announcements highlight the diverse applications within health tech. Talkiatry offers virtual mental health services, addressing a range of psychiatric conditions through online platforms. Honest Health focuses on operational support and insights for value-based care models, partnering with existing health systems. Solace assists patients, particularly Medicare and Medicare Advantage members, by coordinating appointments and treatment plans via advocates. Garner Health leverages a vast database to recommend high-performing providers and reimburses patients for costs, aiming to improve healthcare access. Midi Health specializes in women’s health, providing virtual care for issues like mental health challenges and physical symptoms during menopause, including medications, supplements, and coaching. All these companies are using their funding to scale operations, as detailed in the Dealbreaker article.
Market Context
The health tech sector has been experiencing increased investment interest due to growing demand for digital health solutions, especially in mental health and value-based care, though this wave of funding reflects ongoing trends in addressing healthcare inefficiencies. For context, the broader venture capital market has seen sustained activity in health innovations amid post-pandemic shifts.
What This Means for Emerging Managers
These fundraises demonstrate strong investor appetite for health tech innovations, potentially offering opportunities for emerging managers raising Fund I or II to target similar sectors. According to Dealbreaker, the influx of capital into companies like Talkiatry and Honest Health could signal pathways for new funds to back early-stage health tech ventures, emphasizing areas such as technology enhancement and market expansion. As these firms plan to grow their networks and platforms, emerging managers might find strategic alliances or co-investment prospects in this space.
